What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Fixing overspending issues is essential for financial stability. Explore practical strategies to regain control over your budget.
7,228 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
The spring 2026 Trustees Report shows social security’s trillion funding gap has grown to roughly $30 trillion, accel...
A disturbing online scam pretends to grant workers compensation awards. Victims are then hit with nonrefundable fees....
Negotiating an auto loan at the dealership isn’t just about the monthly payment. This guide shows you how to lock in ...
C2 Financial announced a nationwide expansion to reclaim its No. 1 wholesale ranking. The plan centers on AI upgrades...
Bitwise CIO Matt Hougan rejects blame for Bitcoin's decline, framing it as a crypto winter phenomenon driven by risk ...
Vitalik Buterin unveils a plan to overhaul Ethereum’s execution layer, targeting state tree and VM bottlenecks to unl...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
President Trump announces plans for the first new U.S. oil refinery in nearly five decades, backed by Reliance Indust...
Since 2020, five magnificent stocks have split their shares. Only Alphabet and Tesla outpaced the market, proving tha...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
JPMorgan Chase CEO Jamie Dimon warned that U.S. defense procurement has shifted toward European-style bureaucracy, po...